GLUE
Monte Rosa Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website monterosatx.com
- Employees(FY) 133
- ISIN US61225M1027
Performance
-7.63%
1W
+1.94%
1M
+59.19%
3M
+137.19%
6M
+67.08%
YTD
+124.76%
1Y
Profile
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops an orally bioavailable molecular glue degrader for GSPT1, a a translation termination factor for the treatment of Myc-driven cancers. It also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as gout and Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and a therapeutically-relevant protein in hemoglobinopathies. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.
Technical Analysis of GLUE 2024-12-09
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-06 07:11
- 2024-12-05 07:00
- 2024-12-04 18:00
- 2024-12-02 17:44
- 2024-11-26 07:00
- 2024-11-25 18:00
- 2024-11-14 20:55
- 2024-11-13 07:00
- 2024-11-12 18:00
- 2024-11-11 07:45
- 2024-11-07 08:35
- 2024-11-07 07:30
Monte Rosa Therapeutics: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-07 07:00
- 2024-11-06 18:00
- 2024-11-06 12:00
- 2024-10-30 09:55
- 2024-10-29 11:50
- 2024-10-29 10:57
- 2024-10-28 17:40
Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis(Investor's Business Daily)
- 2024-10-28 14:37
Top Midday Gainers(MT Newswires)
- 2024-10-28 14:26
- 2024-10-28 10:38
- 2024-10-28 07:47
- 2024-10-28 07:33
Monte Rosa joins with Novartis in ‘molecular glue’ drug deal(BioPharma Dive)
- 2024-10-28 02:26
- 2024-10-28 02:10
- 2024-10-27 20:53
- 2024-10-27 20:46
Why Is Monte Rosa Therapeutics Stock Surging On Monday?(Yahoo Finance)
- 2024-10-27 19:00
- 2024-10-22 19:00
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.